Prevalence of Alopecia Areata in Japan: Estimates from a Nationally Representative Sample

The study estimated the prevalence of alopecia areata (AA) in Japan using a nationally representative sample of 45,006 participants, finding a participant-reported point prevalence of 2.18% and a physician-adjusted point prevalence of 1.45%. It highlighted significant emotional and social impacts on individuals, with 75% reporting negative effects on quality of life, yet 43.57% had never been treated. The study emphasized the need for increased physician education and awareness due to misdiagnosis and societal attitudes contributing to undertreatment. Limitations included potential biases, low photo submission rates, and the exclusion of pediatric experiences. The study was funded by Eli Lilly & Company, with some authors having potential conflicts of interest.